Molbio Diagnostics Limited IPO
Molbio Diagnostics Limited was a mainboard IPO to raise ₹940 crore. The issue was subscribed 70.26× overall (QIBs 186.39×, NIIs 49.8×, retail 12.96×). It listed on 17 Aug 2026 at ₹980 and closed its first day at ₹1,042, a listing gain of +29.1% versus the ₹807 issue price. It now trades around ₹1,382 (+71.2% versus the issue price).
Frequently asked questions
- How many times was the Molbio Diagnostics Limited IPO subscribed?
- The Molbio Diagnostics Limited IPO was subscribed 70.26× overall — 186.39× in the QIB category, 49.8× among non-institutional investors, 12.96× in retail.
- What were the Molbio Diagnostics Limited IPO listing gains?
- Molbio Diagnostics Limited listed on 17 Aug 2026 at ₹980, closing its first day at ₹1,042 — a listing gain of +29.1% versus the ₹807 issue price.
- What were the retail allotment odds for the Molbio Diagnostics Limited IPO?
- Retail was subscribed 12.96×, so a single-lot application had roughly a 7.7% chance of allotment (about 1 in 13), and allotment was finalised on 13 Aug 2026.
- Who were the registrar and lead manager for the Molbio Diagnostics Limited IPO?
- KFin Technologies Limited was the registrar to the issue.